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A 59-y e a r-old fe male with s pontaneous painful e cchy-
moses d e v e lope d e c chymoses a fter intracuta n e ous inj e c-
t ion of washed autologous whole blood cells and calf 
thymus DNA_ Immunofluoresc e nt studies of the sponta -
n e ous lesions r e v eale d gra nular depos its of I gM, C 3, 
f actor B and prope rdin at the d e rmal-e pide rma l junction 
but no d e pos its in her nor mal s kin. T cells were d e-
c r e a sed in numbe r but r esponde d normally to polyclonal 
mitoge ns a nd did not tra nsform in res ponse to DNA-
containing a ntige n s . Repair o f UV-damage d DNA by h er 
l y mphocy t es appear e d to b e d e pre ssed. The findings pre -
sen ted h e r e a re the firs t immunologic abnormalities un-
c ove r e d in this dis orde r a nd m ay h e lp in unde r s tanding 
t h e pathoge n e sis of the infla mmatory le sions s een in 
aut o sen s itization to DNA. 
D N A in its native state is not a n t igenic in n ormal a nima ls. 
H owever, in patie n ts wit h systemic lupus eryth e m atosus (SLE), 
th ere m ay be circula ting a n t ibodies to DNA [1] as well as s kin 
test r eactivi ty to injected DNA [2]. A ra r er disorder , a u tosen -
s it izatio n to DNA, is ch a racterized a lso by skin test r eactivi ty 
to injected DNA, but clinical presen ts as recurren t pa inful 
ecchy m oses w it h ou t o the r systemic m a nifestat io ns. S ince 1961 
w h e n Levin a nd Pinkus first re p or ted a patie n t wit h t his syn-
dl'om e, t h e path o physio logy h as re m a ined o bscure [3]. 
W e r e por t a patien t wi t h c h ar acteristic clinical findings, skin 
test reactivi ty to DNA and t h e first la bor a to ry evide nce to 
s uggest a n immunologic basis fo r t h e skin lesio ns in a u tosens i-
t izatio n to DNA . Compa risons a r e also m a d e between t his 
syndrom e, a utoeryth rocyte sens it izatio n and SLE. 
CASE R EPORT 
FK, a 59-yr-old female, presented in the outpatient clinic at the 
Arizona Health Sciences Center in 1972 wi th painful ecchymoses of her 
face, arms and legs of 4 mo duration. T he lesions suddenly a nd spon-
taneously appear ed on her palms, lip, chin, arms a nd legs. On 2 
occasions there was pharyngeal involvement wi th swelling and mild 
respiJ"ato ry distress. The lesions began as warm, red, ra i ed, tender 
nodules, 0.5 to 2.0 cm in dia meter, which initially fe lt numb as swelling 
occurred, but progressed over several hours to larger, pa inful ecchy-
moses. Lesions began in one area, but soon appeared in crops in other 
areas. Individual lesions usually cleared within 48 hr but entire episodes 
lasted from 4 to 10 days and OCCUlTed at 1 to 2 week in tervals. 
She had taken diethylstilbesterol for 2 mo prior to the onset, bu t its 
discontinuation had no effect. T here was no rena l or join t involvement , 
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Abbrevia tions: 
Con A: concanavalin A 
RAST: radioallergosorbent test 
SLE: systemic lupus erythematosus 
no previous easy bruisabili ty, nor a family history of similar ill ness. 
A ide from the ecchymoses and several carious teeth , physical exami-
nation was unremarkable. 
The CBC, different ial, whi te blood count, plate let count, proth rom-
bin t ime, partial thromboplastin t ime, serum prot.e in electrophoresis, 
BUN, urinalysis a nd urinary porphyrins were negative. Chest and sinus 
radiographs and an electrocardiogram were negative. During attacks of 
ecchymo es the Westergren erythrocyte sedimentation rate was 42 a nd 
48 ml/hr. Complement studies during 2 episodes shows mildly de-
creased CH50 values, but norma l levels of C3, C4, C5 by quantitative 
radia l immunodiffusion. On 4 other occasions all complement studies, 
including CH50 were normal. Assay fo r Cl q immune complexes, a 
measure of circulating immune complexes, was negative. Cl esterase 
inhibi tor level was normal. A tourniquet test was fo llowed by heat and 
swelling of her fo rearm which persisted for 72 hr. Antinuclear a nt ibody 
determinations on 2 occasions showed trace patchy nuclear strain at 1: 
4 dilu t ion, but was negative on four other occasions . LE prep was 
negative. Studies fo r antibody to mi tochondria, smooth muscle and 
parietal cells were a lso negative. 
Exclusion of aspir in, food dyes, preservatives and a variety of foods 
as well as extraction of carious teeth had no effect. T herapeut ic trials 
with chlorpheni ramine, cyproheptadine and hydroxychloroquine were 
without effect. S he was mainta ined on prednisone, varying from 5 mg 
on a lte rnate to 30 mg each morning which appeared to abort the 
episodes. Fina lly, she developed angina pectoris, was placed on pro-
pranolol, and her lesions dec reased to the point where steroids were 
discontinued and there have been no exacerbations fo r more than 1 yr. 
M ATER IALS A N D METH ODS 
Shin T elit Materials 
Autologous leukocytes were separated from heparinized blood by 
dextran sed imentation, washed 3 t imes in sterile saline, suspended at 
100; cells per ml, then lysed by 10 cycles of alternate freez ing in carbon 
dioxide snow a nd thawing at 37° after the method of Schwartz, Lewis, 
and Dameshek [4). Afte r removing the leukocyte-rich plasma, eryth-
rocytes were washed , suspended in saline, a nd lysed [4" Autologous 
whi te blood cells were washed 3 t imes in saline but not lysed prior to 
injection. 
Calf thymus DNA (Worthington Biochemica ls, Freehold, N. J.) was 
dissolved in 0.01 M phosphate buffered 0.15 M NaCl, pH 7.4 (PBS) 
containing 0.003 M MgCb by agitation at 4°C for 72 h r. A 1 mg/ ml 
solu t ion was passed through 0.45 ~l pore-size micropore fi lter a nd placed 
in a sterile via l fo r testing. 
A nti-DNA A ll tibodieli 
Radioimmunoa says for antibodies to native DNA, heat-denatured 
DNA, deoxyri bonucleoprotein and circulating free DNA were per-
fo rmed as desc ribed previously [5]. Radioallergosorbent test (RAST) 
fo r anti bodies to native DNA and heat-denatured DNA were kindly 
perfo rmed by Dr. Donald Hoffman, Depar tment of Pathology, East 
Carolina University, Greenville, North Carolina, as described elsewhere 
[6,7]. 
Sk ill Biopsies 
Four-millimeter punch biopsies were taken from the upper arm with 
red, wa rm , raised lesions which had not yet progressed to ecchymoses, 
as well as from normal skin. A biopsy of 1 lesion was sectioned in 2, 
one-ha lf placed in 10% fo rmalin, a nd t he other snap-frozen in T issue 
Tec (Ames Laboratories, E lkhardt, Indiana) fo r frozen sections. Four 
micrometer sections were cut at -20°C, placed on glass slides a nd air-
dl·ied. 
lmmullofluorelicent Studies 
Direct flu orescent a nt ibody studies were per fo rmed using fluores-
ceinated a nt ihuman C3 and ant ihuma n immunoglobu lin ant isera as 
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described previously [8]. Rabbit antihuman properdin was prepared as 
described previously [9]. Rabbit antihuman factor Band C4 were 
kindly supplied by Dr. H. Muller-Eberhard. Antiserum to UV-irradi-
ated DNA was prepared in rabbits and UV treatment of sections was 
prepared as described elsewhere [10]. Fluoresceinated sheep antiJ'a bbit 
globulin was purchased from Meloy Laboratories, Springfield, Virginia 
and absorbed twice with normal human serum , 2 parts conjugate to 1 
part serum. Indirect immunof1uorescence was performed as follows: 10 
min PBS wash, specific rabbit antiserum incubation of section for 30 
min, 10 min PBS wash, sheep antirabbit f1uoresceinated a ntiserum 
incubation of section, 10 min PBS wash, and fina lly 50% glycerol in 
PBS before mounting with a glass coverslip. 
Guinea pig lip and normal skin were used as substrates over which 
serum was layered to test for circulating antibasement membrane 
antibodies. Indirect immunof1uorescence was performed as outlined 
above using rabbit ant ihuman immunoglobu lin f1uoresceinated antise-
rum. 
Controls for the specificity of conjugated antisera to immunoglobulin 
and C3 were performed by absorption of the conjugates with unconju-
gated immunoglobulins or C3 which a bolished the ir staining as de-
scribed previously [8]. Absorbed fluoresceinated sheep antirabbit glob-
ulin produced no staining when applied to sections directly or to 
sections previously incubated with unconjugated normal rabbit serum. 
Cellular Studies 
T cells were enumerated by counting sheep erythrocyte [E] rosettes 
a nd B cell surface immunoglobulin distribution was evaluated by direct 
immunof1uorescence as outlined elsewhere [11]. 
Lymphocyte transformation studies were carried out in trip licate 
using phytohemagglutinin (Difco Laboratories, Detroit, Michigan) , 
pokeweed mitogen (Grand Island Biologicals, Grand Island, New York) 
and concanavalin A (Con A) (Pharmacia Laboratories, Piscataway, 
New J ersey) at concentrations of 20,200 and 200 mg per ml as described 
elsewhere [121- Calf thymus DNA was prepared in native, heat-dena-
tured and UV -altered forms as described elsewhere [5,10] and used in 
concentrations of 0.5, 1.0, 5.0, 25 and 125 mg/ ml in lymphocyte trans-
formation as outlined elsewhere [13]. 
UV -DNA repair was performed by a method previously described 
[141 as follows: Lymphocytes were obtained and suspended in culture 
medium with hydroxyurea for synchronization in G-1 of cell cycle. Cells 
were irradiat.ed at 25.6 nM and returned to culture with tritiated 
thymidine. The uptake of label was measured and compared to aliquots 
of unirradiated ce lls and cells from normal individuals treated in an 
identical manner. 
Pholography 
Fluorescent antibody slides were examined on a Leitz Ortholux 
microscope with a darkfield condenser. Polaroid ASA 3000 film was 
used for exposure periods of 45 to 90 seconds [8]. 
RESULTS 
At 15 min after intracutaneous injection of autologous whole 
blood, lysed leukocytes and calf thymus DNA into the patient, 
wheal and flare responses appeared at these sites. At 4 hr, 
painful red, raised lesions appeared, enlarging until 24 hr at 
which time painful ecchymotic lesions developed, which dimin-
ished in size and faded over the ensuing 96 hr. In contrast, a 
control individual who received identically treated autologous 
blood cells developed only a pale red, non tender area 8 mm in 
diameter by 24 hI' which disappeared within 3 days. When the 
control individual received calf thymus DNA, the maximum 
size of the induced lesion was 5 mm in diameter at 4 hr which 
subsided by 24 hr. However, in the patient, calf thymus DNA 
produced a 10 mm in diameter wheal at 15 min, followed by a 
20 mm in diameter, tender, indurated lesion which began to 
diminish by 24 hr when an ecchymosis appeared. The skin test 
results are summarized in Table 1. 
Radioimmunoassays for circulating antibodies to native DNA 
and to deoxyribonucleoprotein were negative and no free DNA 
was found in the serum. RAST studies for specific IgE anti-
bodies to native DNA and heat-denatured DNA were negative. 
Immunofluorescent studies of the skin lesions revealed stip-
pled fluorescence at the dermal-epidermal junction for C3, IgM, 
properdin and factor B (see Figure, a-e). No deposits of IgG, 
IgA, or C4 were found. Irregular, lumpy deposits were most 
Vol. 72, No.4 
TABLE 1. In.lracutan.eow; le:;l" 
Time after injection 
Injected malerial Wheal Induration 
15 min 4 hr 18 hr 24 hr 
Washed blood cells 2+" 3+ 3+ 4+ 
Lysed erythrocytes Neg Neg Neg Neg 
Lysed leukocytes 2+ 2+ 2+ 1+ 
Ca lf thymus DNA 2+ 2+ 2+ 1+ 
Saline control Neg Neg Neg Neg 
" 1+ = 3-5mm, 2+ = 6-10mm, 3+ = 11-20mm, 4+ = > 20mm. 
striking for C3 and IgM (Figure, a and b). Sections of normal 
skin from this patient were negative by immunofluorescence. 
Routine histologic examination of an early lesion revealed solar 
elastosis but otherwise was negative. 
Tissue sections of lesions irradiated with ultraviolet light and 
stained for DNA using rabbit anti-UV -DN A antiserum revealed 
nuclei in the epidermis and scattered throughout the dermis, 
some nuclear debris, but no definite deposits of DNA at the 
dermal-epidermal junction (Figure, n. If DNA had been present 
in large amounts in this region, UV-irradiation would be ex-
pected to produce a thymidine-dimer photo product detectable 
with rabbit antiserum to UV -DNA. Studies for circulating 
anti basement membrane antibodies using patient's serum with 
guinea pig lip and and normal human skin as substrates failed 
to show tluorescence at the dermal-epidermal junction. 
Lymphocyte studies revealed that T cells comprised only 
11 % of the total as detected by E rosettes (normal 60-70%), and 
were as follows: IgG 15%, IgM 10%, IgA 5%, Kappa 15% and 
Lambda 12%. Lymphocyte transformation studies showed nor-
mal responses to PHA, PWM and Con A. Preparations of N-
DNA, H-DNA and UV-DNA failed to stimulate increased 
thymidine incorporation by lymphocytes. 
Evaluation of DNA repaiT capacities of UV irradiated lym-
phocytes demonstrated that normal individuals show 5.3 times 
the level of incorporation of tritiated thymidine in irradiated 
cells whereas cells from the patient had depressed repair of UV-
damaged DNA with an uptake of only 2.5 times above unin-a-
diated aliquots. This result is identical to those obtained with 
cells from patients with SLE (see Table II) . 
DISCUSSION 
This patient's illness has many features similaJ' to those 
reported in the rare disorder, autosensitization to DNA 
[3,4,15,16]. Her positive skin tests to autologous washed blood 
cells, lysed leukocytes and calf thymus DNA reflect dermal 
sensitivity to DNA [4]. The immediate wheal and flare skin test 
reactivity observed in this patient is characteristic of chemical 
mediator release which can be induced by antigen combining 
with IgE antibody on mast cells or basophils, but complement 
activation via the classical or alternative pathway can generate 
anaphylatoxins which also can trigger mediator release mimick-
ing IgE-mediated reactions [17]. One would expect antibodies 
of the 19E class to have been detected by RAST and antibodies 
of other classes to have been detected by a primary binding 
radioimmunoassay, but these studies were negative. Biopsy 
sections studied by immunofluorescence contained IgM and 
complement at the dermal-epidermal junction but the antigen 
could not be demonstrated. Therefore, only meager evidence 
exists for these reactions being antibody-mediated. 
With regard to a cellular basis for the reactions, lymphocytes 
responded normally to polyclonal mitogens PHA, Con A and 
PWM but did not transform when exposed to DNA in several 
forms including native DNA, single-stranded DNA and UV-
irradiated DNA. Normal controls responded in a similar man-
ner. The patient's lymphocytes were not entirely normal, how-
ever, and certain abnormalities were demonstrated including a 
large null cell population lacking surface markers, and de-
pressed repair of UV-damaged DNA [14). In SLE, there also 
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FIG 1. Fluorescent photographs of sections of lesion from patient with autosensitization to DNA (X400). There is granular staining along 
dermal-epidermal junction for (a) C3 (b) IgM (c) C4 is negative (d) factor B (e) properdin are posit ive (f) UV-DNA is detected in nuclei in 
epidermis a nd some nuclear debris to left of a./.,.ow. There is nonspecific stain of keratin a nd derma l layers . A rrows point to dermal-epidermal 
junction. 
TABLE II. Post- UV labeling of lymphocytes synchroll ized in G- l of 
cell cycle 
No. in X-Fold Subj ecls increase group (mean) 
Autosensitization to DNA I 2.5 
SLE 12 2.5 } P <0.01 Contro ls 20 5.3 
may be a large null cell population [19), and depressed repair 
UV-damaged DNA [14], but cellular responses to polyclonal 
mitogens are usually depressed [12) and responses to DNA may 
be increased [13] compared with controls. 
Several findings in this patient bear similarities to previously 
reported findings in SLE including: (1) Skin test reactivity to 
autologous leukocytes and calf thymus DNA [2] (2) decreased 
numbers of T cells and a large null cell population [19] (3) 
deposits of immunoglobulin and complement at the dermal-
epidermal junction in a skin lesion [18) (4) defective repair of 
UV-damaged DNA in lymphocytes [14]. 
The presence of immunoglobulin and complement at the 
dermal-epidermal junction suggests the presence of immune 
complexes but the antigen could not be demonstrated . Whether 
DNA might be present but masked by antibody or somehow 
degraded in situ is not known. Antibody to the dermal-epider-
mal junction itself also could not be demonstrated. The finding 
of IgM, with C3, factor B and properdin along the dermal-
epidermal junction without C4 being demonstrated is of inter-
est. Factor B and properdin are components of the alternative 
pathway which typically may be activated by carbohydrate 
surfaces or immunoglobulin aggregates [20). C3 can be activated 
by either the classical or alternative pathway, following which 
there is activation of later components C5 through C9. IgM is 
capable of producing cell damage via the alternative pathway 
utilizing a system described with C4-deficient guinea pig serum 
or C2 deficient guinea pig serum in which activation of a Cl-
like protein is associated with conversion of factor B [21). A 
similar bypass mechanism involving IgM activation of the al-
ternative pathway might be operative in our patient but this is 
purely speculative. Activation of the classical as well as the 
alternative pathway has been reported in SLE and several other 
diseases [22). The normal level of C3 in our patient does not 
exclude activation since C3 is an abundant protein with a rapid 
turnover rate [23]. Mild depression of CH50 with normal serum 
levels of C3 does not exclude skin fixation of C3 since synthetic 
processes might be able to compensate for complement utili-
zation. 
The differential diagnosis in this form of nonthrombocyto-
penic purpura includes autoerythrocyte sensitization, purpura 
factitia, vasculitic purpura and SLE. Autoerythrocyte sensiti-
zation was described by Gardner and Diamond in 1955 as a 
form of chronic purpura which appeared to follow an injury 
associated with extravasation of blood [24). Their patients 
reacted with ecchymoses to injected autologous whole blood 
cells autologous erythrocytes and erythrocyte stroma. Most 
patients with autoerythrocyte sensitization have had bizarre 
behavior and hypnosis could reproduce the lesions in some so 
that the designation "psychogenic purpura" has been suggested 
for this syndrome [25). In 1 patient both native DNA and 
erythrocytes could induce ecchymoses and C3 was depressed, 
but one cannot be sure that this study was truly double-blind 
[26). Our patient was not neurotic and reacted to injected DNA 
but not to erythrocytes so a diagnosis of autoerythrocyte sen-
sitization or psychogenic purpura was not made. 
Purpura factitia, an apparently self-inflicted disease [27], is 
not a likely diagnosis since some lesions appeared in relatively 
inaccessible areas and saline skin tests were negative with the 
patient unaware as to which sites received saline or test mate-
rials. 
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Patients with necrotizing angii tis or vasculitis of the skin with 
palpable purpura have had abnormal complement profIles in 
certain instances but these abnormalit ies have correlated best 
with the underlying disease such as SLE, Sjogren's syndrome, 
or rheumatoid arthritis [28]. Nonatopic patients with urticaria 
and chl'onic cutaneous vasculi tis refractory to treatment h ad 
accompanying arthralgias or althritis with or with ou t hypocom-
p le me ntemia [28]. Our patient did not have arth ralgias, nor 
vasculitis on skin biopsy. 
With regard to the differential diagnosis between SLE a nd 
autosensitization to DNA it must be emphasized that t here was 
no re nal or joint involvem e nt or LE cell positivity in our patient 
and t h e present case does not meet the proposed d iagnostic 
criteria for SLE [29]. 
It is not clear how DNA, autologous and heterologous, in-
duced immediate a nd late skin test reactions in this patient, but 
polynucleotides, as well as DNA or partially degraded DNA, 
can react with Clq [30]. DNA, presented properly, might acti-
vate complement with or without the participation of antibody 
or perhaps material with such a large molecular s ize could alter 
skin permeability directly. Posit ive skin tests to DNA which 
have been reported in SLE [2] a lso are not a diagnostic cri terion 
for SLE. Furthermore, our patient lacked antibodies to native 
DNA or deoxyribonucleoprotein which are characteristic of 
SLE [5]. 
The depressed repau' of UV-damaged DNA observed in t his 
patient is in t h e ra nge described for SLE [14] but t he defect is 
much more marked in xeroderma p igmentosum in which vu'-
tually no uptake is found following cell irradiation [31]. D e-
pressed repair of UV- irradiated DNA, a lthough similar to t h e 
defect observed in lymphocytes from SLE patie nts, is not 
suffic ient evid ence to propose autosensit ization to DNA as a 
form of SLE si nce the test is relatively new and has been used 
only in a limited number of d isease states. It is tempting to 
speculate that defective DNA repair in autosensitization to 
DNA and in SLE could gene rate immunogenic material, pos-
sibly overcoming the capacity of nucleases to degrade DNA, 
but further studies would be needed to confIrm t his. 
In summary, in this patient with autosensitization to DNA, 
t he demonstration of immunoglobulin and complemen t com-
ponents along the d ermal-epide rmal junction, decreased num-
bers of T cells and depressed repair of UV damaged DNA 
:uggests that an immunologic process co nt ribu tes to t h e gen-
eration of the skin lesions in this syndrome. Alt h ough a clinical 
diagnosis of SLE cannot be made, t here are severa l common 
features iri t hese 2 diso rders so one ' cannot exclude t h e poss i-
bility that a utose nsitization to DNA may represent a va ria n t of 
SLE. 
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